BOKA Gabor,BOKA Gabor,MIOSSEC Patrick,MIOSSEC Patrick,SILVESTRE Louise,SILVESTRE Louise
申请号:
SI201031342
公开号:
SI2611458T1
申请日:
2010.08.30
申请国别(地区):
SI
年份:
2017
代理人:
摘要:
The present invention refers to the use of Lixisenatide or/and a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of diabetes mellitus type 2, for inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients.